Evidence map›Paper›PMID 37376668›Full record

ArticleViruses2023

Do COVID-19 Vaccinations Affect the Most Common Post-COVID Symptoms? Initial Data from the STOP-COVID Register-12-Month Follow-Up.

Mateusz Babicki, Joanna Kapusta, Karolina Pieniawska-Śmiech, Żaneta Kałuzińska-Kołat, Damian Kołat, Agnieszka Mastalerz-Migas, Piotr Jankowski, Michał Chudzik

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mateusz BabickiDepartment of Family Medicine, Wroclaw Medical University, 51-141 Wroclaw, Poland.ORCID 0000-0002-7719-6959
Joanna KapustaDepartment of Internal Diseases, Rehabilitation and Physical Medicine, Medical University of Lodz, 90-647 Lodz, Poland.ORCID 0000-0002-5082-3641
Karolina Pieniawska-ŚmiechDepartment of Immunology and Pediatrics, The J. Gromkowski Provincial Specialist Hospital, 51-149 Wroclaw, Poland.ORCID 0000-0002-0479-3701
Żaneta Kałuzińska-KołatDepartment of Experimental Surgery, Medical University of Lodz, 90-136 Lodz, Poland.ORCID 0000-0002-2335-3293
Damian KołatDepartment of Experimental Surgery, Medical University of Lodz, 90-136 Lodz, Poland.ORCID 0000-0002-1086-3796
Agnieszka Mastalerz-MigasDepartment of Family Medicine, Wroclaw Medical University, 51-141 Wroclaw, Poland.ORCID 0000-0001-6600-2760
Piotr JankowskiDepartment of Internal Medicine and Geriatric Cardiology, Medical Centre for Postgraduate Education, 01-813 Warsaw, Poland.ORCID 0000-0001-6223-8821
Michał ChudzikDepartment of Internal Medicine and Geriatric Cardiology, Medical Centre for Postgraduate Education, 01-813 Warsaw, Poland.ORCID 0000-0001-8805-9688
Medical University of Lodz · PLWroclaw Medical University · PLPostgraduate School of Molecular Medicine · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Around the world, various vaccines have been developed to prevent the SARS-CoV-2 virus infection and consequently the COVID-19 disease. However, many patients continue to report persistent symptoms after the acute phase. Since gathering scientific information on long COVID and post-COVID syndrome has become an urgent issue, we decided to investigate them in relation to the vaccination status of patients from the STOP-COVID registry. In this retrospective study, we analyzed data from the medical visit after contraction of COVID-19 and follow-up visits in the 3rd and 12th month after the disease. In total, 801 patients were included in the analysis. The most frequent complaints after 12 months included deterioration of exercise tolerance (37.5%), fatigue (36.3%), and memory/concentration difficulties (36.3%). In total, 119 patients declared that they had been diagnosed with at least one new chronic disease since the end of isolation, and 10.6% required hospitalization. The analysis of individual symptoms revealed that headache (

Indexed as

COVID-19COVID-19 VaccinesFollow-Up StudiesHeadacheHumansPost-Acute COVID-19 SyndromeRetrospective StudiesSARS-CoV-2VaccinationCOVID-19 VaccinesCOVID-19COVID-19 vaccinationlong COVIDpersistent symptomspost-COVIDvaccine effectiveness

Identifiers

PMID37376668
PMCPMC10304551
OpenAlexW4380681559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.